Metro NYC acquisition expected to provide broader access to comprehensive testing and laboratory services for patients and physicians

BURLINGTON, N.C. (Feb. 9, 2026) - Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has completed its acquisition of select assets of the clinical laboratory business of Brooklyn, N.Y.-based Empire City Laboratories, Inc., including select existing patient service centers (PSCs).

This strategic acquisition builds upon a longstanding relationship between the two organizations and will expand access to laboratory collection and testing services for Empire's patients and providers, who will benefit from Labcorp's expansive menu of routine and specialty testing, robust data analytics and digital tools like Diagnostic Assistant and Test Finder.

"By combining Empire City Labs' trusted local service with Labcorp's expansive resources and expertise, this acquisition represents an exciting opportunity to deliver even greater value to physicians and patients in the metro New York City area," said Bill Haas, SVP, Labcorp Northeast Division. "We are committed to continuing to provide compassionate, high-quality care that Empire's patients and providers have come to expect and deserve while enhancing access to testing services in practice and through Labcorp's expansive patient service center footprint."

"More than 20 years ago, this company started with a small team, a big idea, and a lot of long nights. We grew it one relationship, one physician, and one patient at a time. Choosing to sell to the premier laboratory in our industry wasn't an easy decision, but it was the right one. Labcorp shares our values and has the resources to carry what we built even further. I'm incredibly proud of our people, deeply grateful to our clients, and more excited for the patients in our communities than ever before," said Steve Nisan, founder of Empire City Laboratories.

"From the very beginning, Empire City Labs has been guided by a simple principle: doing right by our clients and the patients they serve by delivering accurate, dependable results in a timely fashion," said Michael Nisan, CEO & COO of Empire City Laboratories. "This transaction with Labcorp builds on that commitment by expanding our capabilities and reach while preserving the focus on high-quality care that defines both organizations. We're excited about this next chapter and confident it will bring meaningful benefits to our communities."

This acquisition follows other strategic relationships that Labcorp has developed with a range of health systems and regional/local laboratories that have increased access to laboratory services, improved patient care and driven efficiencies for customers.

About LabcorpLabcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at https://www.labcorp.com.

MediaNeil [email protected]

InvestorsChristin O'[email protected]